RATIONALE: The default mode network (DMN), one of several resting-state networks (RSN) in the brain, is thought to be involved in self-referential thought, awareness, and episodic memories. Nicotine improves cognitive performance, in part by improving attention. Nicotinic agonists have been shown to decrease activity in regions within DMN and increase activity in regions involved in visual attention during effortful processing of external stimuli. It is unknown if these pharmacological effects also occur in the absence of effortful processing. OBJECTIVES: This study aims to determine if nicotine suppresses activity in default mode and enhances activity in extra-striate RSNs in the absence of an external visual task. METHODS: Within-subject, single-blinded, counterbalanced study of 19 non-smoking subjects who had resting functional MRI scans after 7 mgnicotine or placebo patch. Group independent component analysis was performed. The DMN component was identified by spatial correlation with a reference DMN mask. A visual attention component was identified by spatial correlation with an extra-striate mask. Analyses were conducted using statistical parametric mapping. RESULTS:Nicotine was associated with decreased activity in regions within the DMN and increased activity in extra-striate regions. CONCLUSIONS: Suppression of DMN and enhancement of extra-striate resting-state activity in the absence of visual stimuli or effortful processing suggest that nicotine's cognitive effects may involve a shift in activity from networks that process internal to those that process external information. This is a potential mechanism by which cholinergic agonists may have a beneficial effect in diseases associated with altered resting-state activity.
RCT Entities:
RATIONALE: The default mode network (DMN), one of several resting-state networks (RSN) in the brain, is thought to be involved in self-referential thought, awareness, and episodic memories. Nicotine improves cognitive performance, in part by improving attention. Nicotinic agonists have been shown to decrease activity in regions within DMN and increase activity in regions involved in visual attention during effortful processing of external stimuli. It is unknown if these pharmacological effects also occur in the absence of effortful processing. OBJECTIVES: This study aims to determine if nicotine suppresses activity in default mode and enhances activity in extra-striate RSNs in the absence of an external visual task. METHODS: Within-subject, single-blinded, counterbalanced study of 19 non-smoking subjects who had resting functional MRI scans after 7 mg nicotine or placebo patch. Group independent component analysis was performed. The DMN component was identified by spatial correlation with a reference DMN mask. A visual attention component was identified by spatial correlation with an extra-striate mask. Analyses were conducted using statistical parametric mapping. RESULTS:Nicotine was associated with decreased activity in regions within the DMN and increased activity in extra-striate regions. CONCLUSIONS: Suppression of DMN and enhancement of extra-striate resting-state activity in the absence of visual stimuli or effortful processing suggest that nicotine's cognitive effects may involve a shift in activity from networks that process internal to those that process external information. This is a potential mechanism by which cholinergic agonists may have a beneficial effect in diseases associated with altered resting-state activity.
Authors: D Cordes; V M Haughton; K Arfanakis; J D Carew; P A Turski; C H Moritz; M A Quigley; M E Meyerand Journal: AJNR Am J Neuroradiol Date: 2001-08 Impact factor: 3.825
Authors: Veronika Schöpf; Christian Windischberger; Christian H Kasess; Rupert Lanzenberger; Ewald Moser Journal: MAGMA Date: 2010-06-03 Impact factor: 2.310
Authors: Michael D Greicius; Vesa Kiviniemi; Osmo Tervonen; Vilho Vainionpää; Seppo Alahuhta; Allan L Reiss; Vinod Menon Journal: Hum Brain Mapp Date: 2008-07 Impact factor: 5.038
Authors: Michael D Greicius; Benjamin H Flores; Vinod Menon; Gary H Glover; Hugh B Solvason; Heather Kenna; Allan L Reiss; Alan F Schatzberg Journal: Biol Psychiatry Date: 2007-01-08 Impact factor: 13.382
Authors: Abigail G Garrity; Godfrey D Pearlson; Kristen McKiernan; Dan Lloyd; Kent A Kiehl; Vince D Calhoun Journal: Am J Psychiatry Date: 2007-03 Impact factor: 18.112
Authors: Matthew T Sutherland; Kimberly L Ray; Michael C Riedel; Julio A Yanes; Elliot A Stein; Angela R Laird Journal: Biol Psychiatry Date: 2015-01-07 Impact factor: 13.382
Authors: Najmeh Khalili-Mahani; Serge A R B Rombouts; Matthias J P van Osch; Eugene P Duff; Felix Carbonell; Lisa D Nickerson; Lino Becerra; Albert Dahan; Alan C Evans; Jean-Paul Soucy; Richard Wise; Alex P Zijdenbos; Joop M van Gerven Journal: Hum Brain Mapp Date: 2017-02-01 Impact factor: 5.038
Authors: Manish S Dalwani; Jason R Tregellas; Jessica R Andrews-Hanna; Susan K Mikulich-Gilbertson; Kristen M Raymond; Marie T Banich; Thomas J Crowley; Joseph T Sakai Journal: Drug Alcohol Depend Date: 2013-10-24 Impact factor: 4.492
Authors: K J Bough; C Lerman; J E Rose; F J McClernon; P J Kenny; R F Tyndale; S P David; E A Stein; G R Uhl; D V Conti; C Green; S Amur Journal: Clin Pharmacol Ther Date: 2013-03-18 Impact factor: 6.875